Page results
-
Information about the Integrative Talking Therapies service at the Royal London Hospital for Integrated Medicine.
-
The Neuroimmunology and CSF Laboratory at the Institute of Neurology, UCLH is a UKAS accredited medical laboratory No. 8045.
-
Our annual members' meeting (AMM) brings together members, governors and staff, and is where our governors officially receive our annual report and accounts.
-
This service provides a tertiary level, second opinion service, specialising in the diagnostic assessment and treatment of complex speech sound disorders. The team has particular expertise in Childhood Apraxia of Speech (CAS).
-
Health and wellbeing information for people affected by cancer.
-
This information aims to support and supplement the information provided in the Be Active video available on uclh.nhs.uk/wellbeing
-
Advice on socialising and managing friendships for young people living with fatigue syndromes.
-
This page explains what an intra-oral scanner is and what it is used for.
-
Once again, UCLH has received the highest score of all general acute and acute/community NHS trusts in England for staff that would recommend us as a place to work
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
File results
-
FOI/2022/0675 - Drug treatment for Paediatric patients (ages 0-16)
-
FOI/2022/0677 - Documents relating to the lift being out of order (RLHIM Lift 2 by reception)
-
FOI/2022/0679 - Theatre management, AA's and ODPs
-
FOI/2022/0681 - Deep brain stimulation procedure
-
FOI/2022/0686 - Breast cancer patients
-
FOI/2022/0692 - Respiratory diagnostic equipment
-
FOI/2022/0696 - Trust complaints policy and discrimination and diversity policy
-
FOI/2022/0704 - Elective operations cancelled for non-clinical reasons
-
FOI/2022/0705 - Head/ neck and urothelial cancer treatment
-
FOI/2022/0707 - Current endoscopy maintenance supplier and the contract expiry date